Israel Englander’s Research Alliance Corp. II Class A Common Stock RACB Stock Holding History

Israel Englander’s Portfolio RACB Stock Details RACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-149,973	Closed	-$1.47M	–	7588
2022 Q3	$1.47M	Sell	149,973 -14,620	-9%	-$143K	﹤0.01%	4017
2022 Q2	$1.61M	Sell	164,593 -47,043	-22%	-$460K	﹤0.01%	3920
2022 Q1	$2.07M	Sell	211,636 -26,877	-11%	-$262K	﹤0.01%	3851
2021 Q4	$2.33M	Sell	238,513 -3,229	-1%	-$31.8K	﹤0.01%	3632
2021 Q3	$2.38M	Sell	241,742 -46,987	-16%	-$465K	﹤0.01%	3713
2021 Q2	$2.93M	Buy	288,729 +24,161	+9%	+$255K	﹤0.01%	3473
2021 Q1	$2.71M	Buy	+264,568	New	+$2.71M	﹤0.01%	3235

Israel Englander's RACB Position: Q4 2022 in Review

Israel Englander sold out of Research Alliance Corp. II Class A Common Stock (RACB) in Q4 2022, closing a stake of 149,973 shares — an estimated $1.47M sold.

Israel Englander first reported a position in RACB in Q1 2021 and held it in 7 quarters. The position peaked at $2.93M in Q2 2021. 0 funds tracked by Wall St. Rank hold RACB as of Q4 2022.

Israel Englander reported no remaining Research Alliance Corp. II Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Israel Englander sold 149,973 Research Alliance Corp. II Class A Common Stock shares in Q4 2022, an estimated $1.47M.
Israel Englander first reported a position in Research Alliance Corp. II Class A Common Stock in Q1 2021 and held it in 7 quarters.
Israel Englander's Research Alliance Corp. II Class A Common Stock position peaked at $2.93M in Q2 2021.
0 funds tracked by Wall St. Rank held Research Alliance Corp. II Class A Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.